Mural Oncology plc (MURA) Financials

$3.44

north_east
$0.02 (0.58%)
Day's range
$3.36
Day's range
$3.5

MURA Income statement / Annual

Last year (2024), Mural Oncology plc's total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Mural Oncology plc's net income was -$128.51 M. See Mural Oncology plc,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Operating Revenue $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $2.57 M $1.54 M $1.47 M
Gross Profit $0.00 -$2.57 M -$1.54 M -$1.47 M
Gross Profit Ratio 0 0 0 0
Research and Development Expenses $110.67 M $162.03 M $170.07 M $159.82 M
General & Administrative Expenses $27.60 M $30.71 M $25.08 M $15.55 M
Selling & Marketing Expenses $0.00 -$667,000.00 $0.00 $0.00
Selling, General & Administrative Expenses $27.60 M $30.04 M $25.08 M $15.55 M
Other Expenses $0.00 $0.00 $0.00 $0.00
Operating Expenses $138.26 M $192.07 M $195.15 M $175.37 M
Cost And Expenses $0.00 $194.64 M $195.15 M $175.37 M
Interest Income $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $0.00 $2.57 M $1.54 M $1.47 M
EBITDA $0.00 -$192.72 M -$183.38 M -$173.89 M
EBITDA Ratio 0 0 0 0
Operating Income Ratio 0 0 0 0
Total Other Income/Expenses Net $0.00 -$649,000.00 $10.22 M $0.00
Income Before Tax -$128.51 M -$195.29 M -$195.15 M -$175.37 M
Income Before Tax Ratio 0 0 0 0
Income Tax Expense $0.00 $12.16 M $4.88 M $68,000.00
Net Income -$128.51 M -$207.45 M -$200.03 M -$175.43 M
Net Income Ratio 0 0 0 0
EPS -7.58 -12.43 -11.99 -10.51
EPS Diluted -7.58 -12.43 -11.99 -10.51
Weighted Average Shares Out $16.95 M $16.69 M $16.69 M $16.69 M
Weighted Average Shares Out Diluted $16.95 M $16.69 M $16.69 M $16.69 M
Link